BIOCONNSEBIOCON LIMITED.· PharmaceuticalsMediumNeutral
Announced Wed, 22 Jul · 19:50 IST

Independent Director Bobby Parikh completes second term, ceases to be Director

Management Changes View source PDF

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.1%1-day move
₹438.45
prior close
₹435.75
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.2-0.4-1.3-1.1-0.4
Up moveDown movePending
AI summary

Mr. Bobby Kanubhai Parikh, Independent Director of Biocon, completed his second term and ceased to be a Director effective close of business on July 22, 2026. The Board recorded appreciation for his stewardship and contribution. This is a routine end-of-tenure event disclosed under SEBI Listing Regulations, not a resignation.

Likely market impact

Routine board change with an Independent Director completing his second term. No material impact on operations, financials, or governance.